Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease

Journal of Neuroscience

Volumn 33, Issue 25, 2013, Pages 10471-10482

  Valor, Luis M ^a   Guiretti, Deisy ^a   Lopez Atalaya, Jose P ^a   Barco, Angel ^a  

^a INSTITUTO DE NEUROCIENCIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPIGENETICS; GENE EXPRESSION; GENETIC DISORDER; GENOME; HIPPOCAMPUS; HISTONE ACETYLATION; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROARRAY ANALYSIS; MOUSE; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYGLUTAMINE DISEASE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING;

ACETYLATION; ANIMALS; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; BRAIN; CHROMATIN IMMUNOPRECIPITATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; HISTONES; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICROARRAY ANALYSIS; NERVOUS SYSTEM DISEASES; PEPTIDES; REAL-TIME POLYMERASE CHAIN REACTION; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84879137604     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0670-13.2013     Document Type: Article

References (64)

1. Bedford DC, Brindle PK (2012) Is histone acetylation the most important physiological function for CBP and p300? Aging 4:247-255. Medline
2. Bernstein BE, et al. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489:57-74. CrossRef Medline
3. Bowles KR, Brooks SP, Dunnett SB, Jones L (2012) Gene expression and behaviour in mouse models of HD. Brain Res Bull 88:276-284. CrossRef Medline
4. Buckley NJ, Johnson R, Zuccato C, Bithell A, Cattaneo E (2010) The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease. Neurobiol Dis 39:28-39. CrossRef Medline
5. Cha JH (2000) Transcriptional dysregulation in Huntington's disease. Trends Neurosci 23:387-392. CrossRef Medline
6. Datta M, Bhattacharyya NP (2011) Regulation of RE1 protein silencing transcription factor (REST) expression by HIP1 protein interactor (HIPPI). J Biol Chem 286:33759-33769. CrossRef Medline
7. Dawson MA, Kouzarides T (2012) Cancer epigenetics: from mechanism to therapy. Cell 150:12-27. CrossRef Medline
8. de Cárcer G, Escobar B, Higuero AM, García L, Ansón A, Pérez G, Mollejo M, Manning G, Meléndez B, Abad-Rodríguez J, Malumbres M (2011) Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression. Mol Cell Biol 31:1225-1239. CrossRef Medline
9. Dibbens LM, Feng HJ, Richards MC, Harkin LA, Hodgson BL, Scott D, Jenkins M, Petrou S, Sutherland GR, Scheffer IE, Berkovic SF, Macdonald RL, Mulley JC (2004) GABRD encoding a protein for extraor perisynaptic GABAA receptors is a susceptibility locus for generalized epilepsies. Hum Mol Genet 13:1315-1319. CrossRef Medline
10. Dompierre JP, Godin JD, Charrin BC, Cordelières FP, King SJ, Humbert S, Saudou F (2007) Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J Neurosci 27:3571-3583. CrossRef Medline
11. Gardian G, Browne SE, Choi DK, Klivenyi P, Gregorio J, Kubilus JK, Ryu H, Langley B, Ratan RR, Ferrante RJ, Beal MF (2005) Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J Biol Chem 280:556-563. CrossRef Medline
12. Gatchel JR, Watase K, Thaller C, Carson JP, Jafar-Nejad P, Shaw C, Zu T, Orr HT, Zoghbi HY (2008) The insulin-like growth factor pathway is altered in spinocerebellar ataxia type 1 and type 7. Proc Natl Acad Sci U S A 105:1291-1296. CrossRef Medline
13. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80. CrossRef Medline
14. Giralt A, Puigdellívol M, Carretón O, Paoletti P, Valero J, Parra-Damas A, Saura CA, Alberch J, Ginés S (2012) Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity. Hum Mol Genet 21:1203-1216. CrossRef Medline
15. Henikoff S, Shilatifard A (2011) Histone modification: cause or cog? Trends Genet 27:389-396. CrossRef Medline
16. Hockly E, Cordery PM, Woodman B, Mahal A, van Dellen A, Blakemore C, Lewis CM, Hannan AJ, Bates GP (2002) Environmental enrichment slows disease progression in R6/2 Huntington's disease mice. Ann Neurol 51:235-242. CrossRef Medline
17. Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, Hollingsworth ZR, Collin F, Synek B, Holmans PA, Young AB, Wexler NS, Delorenzi M, Kooperberg C, Augood SJ, Faull RL, et al. (2006) Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet 15:965-977. CrossRef Medline
18. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57. CrossRef Medline
19. Kim MO, Chawla P, Overland RP, Xia E, Sadri-Vakili G, Cha JH (2008) Altered histone monoubiquitylation mediated by mutant huntingtin induces transcriptional dysregulation. J Neurosci 28:3947-3957. CrossRef Medline
20. Klevytska AM, Tebbenkamp AT, Savonenko AV, Borchelt DR (2010) Partial depletion of CREB-binding protein reduces life expectancy in a mouse model of Huntington disease. J Neuropathol Exp Neurol 69:396-404. CrossRef Medline
21. Kuhn A, Goldstein DR, Hodges A, Strand AD, Sengstag T, Kooperberg C, Becanovic K, Pouladi MA, Sathasivam K, Cha JH, Hannan AJ, Hayden MR, Leavitt BR, Dunnett SB, Ferrante RJ, Albin R, Shelbourne P, Delorenzi M, Augood SJ, Faull RL, Olson JM, et al. (2007) Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet 16:1845-1861. CrossRef Medline
22. Lenstra TL, Benschop JJ, Kim T, Schulze JM, Brabers NA, Margaritis T, van de Pasch LA, van Heesch SA, Brok MO, Groot Koerkamp MJ, Ko CW, van Leenen D, Sameith K, van Hooff SR, Lijnzaad P, Kemmeren P, Hentrich T, Kobor MS, Buratowski S, Holstege FC (2011) The specificity and topology of chromatin interaction pathways in yeast. Mol Cell 42:536-549. CrossRef Medline
23. Levenson JM, O'Riordan KJ, Brown KD, Trinh MA, Molfese DL, Sweatt JD (2004) Regulation of histone acetylation during memory formation in the hippocampus. J Biol Chem 279:40545-40559. CrossRef Medline
24. Li H, Durbin R (2010) Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26:589-595. CrossRef Medline
25. Li H, Wyman T, Yu ZX, Li SH, Li XJ (2003) Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release. Hum Mol Genet 12:2021-2030. CrossRef Medline
26. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R (2009) The sequence alignment/map format and SAMtools. Bioinformatics 25:2078-2079. CrossRef Medline
27. Lopez de Armentia M, Jancic D, Olivares R, Alarcon JM, Kandel ER, Barco A (2007) cAMP response element-binding protein-mediated gene expression increases the intrinsic excitability of CA1 pyramidal neurons. J Neurosci 27:13909-13918. CrossRef Medline
28. Lopez-Atalaya JP, Ciccarelli A, Viosca J, Valor LM, Jimenez-Minchan M, Canals S, Giustetto M, Barco A (2011) CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. EMBO J 30:4287-4298. CrossRef Medline
29. MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, Barnes G, Taylor SA, James M, Groot N, MacFarlane H, Jenkins B, Anderson MA, Wexler NS, Gusella JF, Bates GP, Baxendale S, Hummerich H, Kirby S, North M, et al. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72:971-983. CrossRef Medline
30. Marcora E, Kennedy MB (2010) The Huntington's disease mutation impairs Huntington's role in the transport of NF-kappaB from the synapse to the nucleus. Hum Mol Genet 19:4373-4384. CrossRef Medline
31. McFarland KN, Das S, Sun TT, Leyfer D, Xia E, Sangrey GR, Kuhn A, Luthi-Carter R, Clark TW, Sadri-Vakili G, Cha JH (2012) Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease. PLoS ONE 7:e41423. CrossRef Medline
32. Ng CW, Yildirim F, Yap YS, Dalin S, Matthews BJ, Velez PJ, Labadorf A, Housman DE, Fraenkel E (2013) Extensive changes in DNA methylation are associated with expression of mutant huntingtin. Proc Natl Acad Sci U S A 110:2354-2359. CrossRef Medline
33. Oliveros J (2007) Venny: an interactive tool for comparing lists with Venn diagrams. http://bioinfogp.cnb.csic.es/tools/venny/index.html.
34. Orr HT, Zoghbi HY (2007) Trinucleotide repeat disorders. Annu Rev Neurosci 30:575-621. CrossRef Medline
35. Paradiso S, Turner BM, Paulsen JS, Jorge R, Ponto LL, Robinson RG (2008) Neural bases of dysphoria in early Huntington's disease. Psychiatry Res 162:73-87. CrossRef Medline
36. Peleg S, Sananbenesi F, Zovoilis A, Burkhardt S, Bahari-Javan S, Agis-Balboa RC, Cota P, Wittnam JL, Gogol-Doering A, Opitz L, Salinas-Riester G, Dettenhofer M, Kang H, Farinelli L, Chen W, Fischer A (2010) Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 328:753-756. CrossRef Medline
37. Rando OJ (2012) Combinatorial complexity in chromatin structure and function: revisiting the histone code. Curr Opin Genet Dev 22:148-155. CrossRef Medline
38. Ravache M, Weber C, Mérienne K, Trottier Y (2010) Transcriptional activation of REST by Sp1 in Huntington's disease models. PLoS ONE 5:e14311. CrossRef Medline
39. Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP (2011) Integrative genomics viewer. Nat Biotechnol 29:24-26. CrossRef Medline
40. Rodda RA (1981) Cerebellar atrophy in Huntington's disease. J Neurol Sci 50:147-157. CrossRef Medline
41. Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, Caplan K, Marek K, Seidman LJ, Makris N, Jenkins BG, Goldstein JM (2003) Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60:1615-1620. CrossRef Medline
42. Ruocco HH, Bonilha L, Li LM, Lopes-Cendes I, Cendes F (2008) Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat. J Neurol Neurosurg Psychiatry 79:130-135. CrossRef Medline
43. Sadri-Vakili G, Bouzou B, Benn CL, Kim MO, Chawla P, Overland RP, Glajch KE, Xia E, Qiu Z, Hersch SM, Clark TW, Yohrling GJ, Cha JH (2007) Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. Hum Mol Genet 16:1293-1306. CrossRef Medline
44. Saha RN, Pahan K (2006) HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ 13:539-550. CrossRef Medline
45. Sanchis-Segura C, Lopez-Atalaya JP, Barco A (2009) Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition. Neuropsychopharmacology 34:2642-2654. CrossRef Medline
46. Sanyal A, Lajoie BR, Jain G, Dekker J (2012) The long-range interaction landscape of gene promoters. Nature 489:109-113. CrossRef Medline
47. Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA, Slunt HH, Ratovitski T, Cooper JK, Jenkins NA, Copeland NG, Price DL, Ross CA, Borchelt DR (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8:397-407. CrossRef Medline
48. Schubeler D, MacAlpine DM, Scalzo D, Wirbelauer C, Kooperberg C, van Leeuwen F, Gottschling DE, O'Neill LP, Turner BM, Delrow J, Bell SP, Groudine M (2004) The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev 18:1263-1271. CrossRef Medline
49. Seidel K, Siswanto S, Brunt ER, den Dunnen W, Korf HW, Rub U (2012) Brain pathology of spinocerebellar ataxias. Acta Neuropathologica 124:1-21. CrossRef Medline
50. Seneca S, Fagnart D, Keymolen K, Lissens W, Hasaerts D, Debulpaep S, Desprechins B, Liebaers I, De Meirleir L (2004) Early onset Huntington disease: a neuronal degeneration syndrome. Eur J Pediatr 163:717-721. CrossRef Medline
51. Seredenina T, Luthi-Carter R (2012) What have we learned from gene expression profiles in Huntington's disease? Neurobiol Dis 45:83-98. CrossRef Medline
52. Smyth G (2005) Limma: linear models for microarray data. New York: Springer.
53. Snowden JS, Craufurd D, Thompson J, Neary D (2002) Psychomotor, executive, and memory function in preclinical Huntington's disease. J Clin Exp Neuropsychol 24:133-145. CrossRef Medline
54. Stack EC, Del Signore SJ, Luthi-Carter R, Soh BY, Goldstein DR, Matson S, Goodrich S, Markey AL, Cormier K, Hagerty SW, Smith K, Ryu H, Ferrante RJ (2007) Modulation of nucleosome dynamics in Huntington's disease. Hum Mol Genet 16:1164-1175. CrossRef Medline
55. Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403:41-45. CrossRef Medline
56. Valor LM, Pulopulos MM, Jimenez-Minchan M, Olivares R, Lutz B, Barco A (2011) Ablation of CBP in forebrain principal neurons causes modest memory and transcriptional defects and a dramatic reduction of histone acetylation, but does not affect cell viability. J Neurosci 31:1652-1663. CrossRef Medline
57. Valor LM, Viosca J, Lopez-Atalaya JP, Barco A (2013) Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders. Curr Pharm Des. Advance online publication. Retrieved Feb. 19, 2013. doi:10.2174/13816128113199990382. CrossRef Medline
58. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, Cui K, Roh TY, Peng W, Zhang MQ, Zhao K (2008) Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40:897-903. CrossRef Medline
59. Yamanaka T, Miyazaki H, Oyama F, Kurosawa M, Washizu C, Doi H, Nukina N (2008) Mutant huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor. EMBO J 27:827-839. CrossRef Medline
60. Zambelli F, Pesole G, Pavesi G (2009) Pscan: finding over-represented transcription factor binding site motifs in sequences from co-regulated or coexpressed genes. Nucleic Acids Res 37:W247-252. CrossRef Medline
61. Zang C, Schones DE, Zeng C, Cui K, Zhao K, Peng W (2009) A clustering approach for identification of enriched domains from histone modification ChIP-seq data. Bioinformatics 25:1952-1958. CrossRef Medline
62. Zhang LX, Zhao Y, Cheng G, Guo TL, Chin YE, Liu PY, Zhao TC (2010) Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition. Am J Physiol Heart Circ Physiol 298: H2154-2163. CrossRef Medline
63. Zhu LJ, Gazin C, Lawson ND, Pagès H, Lin SM, Lapointe DS, Green MR (2010) ChIPpeakAnno: a bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics 11:237. CrossRef Medline
64. Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiological reviews 90:905-981. CrossRef Medline